About the journal
MedComm is an open-access journal published by Wiley in Australia, publishing in english. It is listed in DOAJ according to the sources read. Declared publication charge: 3,850 USD. Declared review time at DOAJ: 10 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- Wiley
- ISSN
- 2688-2663
- Country
- Australia
- Languages
- english
- Access
- Open access
- Declared publication charge
- 3,850 USD
- Articles in DOAJ
- 1535
- Declared review time
- 10 weeks
- Declared peer-review model
- peer_review
- Official website
- https://onlinelibrary.wiley.com/journal/26882663
Index listings
- DOAJ · 2020-08-19
- Indexing
- DOAJ
- APC
- 3,850 USD
- Declared review time (DOAJ)
- 10 weeks — journal-declared only (not measured)
- Activity (OpenAlex)
- Active — latest works 2026
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Articles in DOAJ
1535
Most recent article
2 months ago
Average review time (journal-declared via DOAJ)
10weeks
Works in OpenAlex
1647
Last recorded publication year
2026
h-index
72
i10-index
563
From OpenAlex open data (CC0).
Editorial & policy12
- Last DOAJ review date
- 2026-03-17
- Added to DOAJ
- 2020-08-19
- Declared plagiarism screening
- Declared
- Other fees beyond APC
- No
- Declared digital preservation
- CLOCKSSPorticoPMC
- Observed digital preservation (Keepers registry)— snapshot 2026-10-05
- CLOCKSSPortico
- Editorial board
- Official page ↗
- Open references deposited at Crossref
- 94%
- ORCID iDs in current deposits
- 56%
- Enrolled in Crossref Similarity Check
- ✓
- Deposits licence metadata at Crossref
- ✓
- APC waiver policy
- View policy
- Peer-review policy
- View policy
Identity & continuity4
- Alternate titles
- Medicine communicationsMedComm open accessMedComm (Beijing
- Source type
- journal
- NLM unique ID (PubMed)
- 101769925
- Society affiliations
- Sichuan International Medical Exchange & Promotion Association (SCIMEA)
Classification2
Subjects (DOAJ)
LCC codes
Subject areas
- Cancer Immunotherapy and Biomarkers
- Cancer Immunotherapy and Biomarkers
- Immune cells in cancer
- Immune cells in cancer
- RNA modifications and cancer
- RNA modifications and cancer
- SARS-CoV-2 and COVID-19 Research
- SARS-CoV-2 and COVID-19 Research
Show all subjects (50)
- Epigenetics and DNA Methylation
- Ferroptosis and cancer prognosis
- Epigenetics and DNA Methylation
- Immune Cell Function and Interaction
- Cancer-related molecular mechanisms research
- Immune Cell Function and Interaction
- Ferroptosis and cancer prognosis
- Cancer-related molecular mechanisms research
- Autophagy in Disease and Therapy
- Cancer, Hypoxia, and Metabolism
- Autophagy in Disease and Therapy
- MicroRNA in disease regulation
- Cancer, Hypoxia, and Metabolism
- MicroRNA in disease regulation
- Immunotherapy and Immune Responses
- Immunotherapy and Immune Responses
- CAR-T cell therapy research
- COVID-19 Clinical Research Studies
- Cancer Cells and Metastasis
- Cancer Cells and Metastasis
- COVID-19 Clinical Research Studies
- CAR-T cell therapy research
- interferon and immune responses
- Extracellular vesicles in disease
- Ubiquitin and proteasome pathways
- interferon and immune responses
- Extracellular vesicles in disease
- Ubiquitin and proteasome pathways
- Gut microbiota and health
- Cancer Genomics and Diagnostics
- Cancer Genomics and Diagnostics
- Gut microbiota and health
- Single-cell and spatial transcriptomics
- RNA Research and Splicing
- Liver Disease Diagnosis and Treatment
- Protein Degradation and Inhibitors
- Protein Degradation and Inhibitors
- Inflammasome and immune disorders
- RNA Research and Splicing
- Inflammasome and immune disorders
- Single-cell and spatial transcriptomics
- Liver Disease Diagnosis and Treatment
Keywords (DOAJ)
- biomedicine
- clinical medicine
- disease treatment
- drug discovery
- pathogenesis
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
The journal's record in other sources:Web of Science MJLDOAJ